Harrow Launches PharmaPack Direct-to-Prescriber Kits for Ophthalmic Medications

Harrow announced the launch of PharmaPack, a new Direct-to-Prescriber (DTP) cash-pay offering designed to expand access to affordable, FDA-approved branded ophthalmic medications.

According to Harrow, by providing transparent, cash-pay pricing directly to prescribers, PharmaPack aims to simplify postoperative medication access while reducing insurance-related administrative complexity and minimizing regulatory and medical-legal risks often associated with compounded products.

“Harrow’s PharmaPack program addresses a long-standing challenge in ophthalmology—providing patients with FDA-approved therapies that are both reliable and affordable,” said Scott Spector, MD. “The combination of trusted branded products, pricing transparency, and these compelling cash-pay prices is encouraging and supports complexity-free prescribing and greater confidence when considering FDA-approved branded alternatives to compounded products. Given the strength of this offering and the value it represents, I have already ordered PharmaPack Prime for my patients.”

PharmaPack kits will initially be available in California, Mississippi, Arkansas, Connecticut, and Alabama, with plans for nationwide expansion in the coming weeks.

Prescribers can access PharmaPack offerings directly from the home screen of their account dashboard or through dedicated ordering links for:

• PharmaPack Max

• PharmaPack Prime

Originally published online on Eyewire+.